Anywhere Dx
Private Company
Total funding raised: $18M
Overview
Anywhere Dx is an early-stage, private diagnostics company building a consumer-centric, disposable diagnostic device to deliver real-time, lab-quality results outside traditional healthcare settings. Led by a team with deep expertise in entrepreneurship, epidemiology, and assay development, the company targets the significant market need for decentralized, scalable, and affordable testing. While still in development and likely pre-revenue, its value proposition lies in disrupting the slow and costly conventional diagnostics model by putting testing directly into users' hands. The company's success hinges on successfully developing and validating its platform, navigating regulatory pathways, and achieving commercial scale against established competitors.
Technology Platform
A fully disposable, single-use diagnostic device designed for consumer use that delivers real-time, lab-quality results. The platform emphasizes ease of use, affordability, and scalability, and is likely based on advanced molecular assay chemistry adapted for a simple format.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Anywhere Dx competes in the broad point-of-care and direct-to-consumer diagnostics market against large incumbents (e.g., Abbott, Roche, QuidelOrtho) and numerous startups developing home-testing and decentralized diagnostic solutions. Its differentiation hinges on achieving a unique combination of disposability, high accuracy, and true ease-of-use.